Background: Refractory ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) refers to cases that do not respond to traditional Advanced Cardiac Life Support measures and are associated with significantly lower survival rates. Beta-blockade may improve outcomes by protecting against the deleterious effects associated with epinephrine's beta-receptor effect.
Objective: This systematic review and meta-analysis aimed to evaluate whether beta-blockade compared with control improved outcomes among patients in cardiac arrest due to refractory VF/VT.
Methods: PubMed, Scopus, CINAHL, LILACS, the Cochrane databases, Google Scholar, and bibliographies of selected articles were assessed on September 2nd, 2019 for all studies evaluating beta-blockade versus control groups in patients with cardiac arrest due to refractory VF/VT. PRISMA guidelines were followed. Data were dual extracted into a predefined worksheet and quality analysis was performed with the Cochrane Risk of Bias in Non-randomised Studies of Interventions tool. Data were summarized and a meta-analysis was performed assessing temporary and sustained return of spontaneous circulation (ROSC), survival-to-admission, survival-to-discharge, and survival with a favorable neurologic outcome.
Results: Three studies (n = 115 patients) were selected for final inclusion. Beta-blockade was associated with an increased rate of temporary ROSC (OR 14.46; 95% CI 3.63-57.57), sustained ROSC (OR 5.76; 95% CI 1.79-18.52), survival-to-admission (OR 5.76; 95% CI 1.79-18.52), survival-to-discharge (OR 7.92; 95% CI 1.85-33.89), and survival with a favorable neurologic outcome (OR 4.42; 95% CI 1.05-18.56). Overall risk of bias ranged from moderate-to-severe, which was primarily influenced by selection of participants and potential confounding. This study was registered with PROSPERO (CRD42019126902).
Conclusions: The data suggest that beta-blockade may be associated with improved outcomes ranging from ROSC to survival with a favorable neurologic outcome. Future randomized controlled trials are needed to further evaluate this intervention in refractory VF/VT.
Keywords: Beta-blockade; Beta-blocker; Cardiac arrest; Esmolol; Propranolol; Ventricular fibrillation; Ventricular tachycardia.
Copyright © 2019 Elsevier B.V. All rights reserved.
Cardiopulmonary Resuscitation (CPR) Plus Delayed Defibrillation Versus Immediate Defibrillation for Out-Of-Hospital Cardiac ArrestY Huang et al. Cochrane Database Syst Rev 2014 (9), CD009803. PMID 25212112. - ReviewOwing to the low quality of available evidence, we have been unable to determine conclusively whether immediate defibrillation and one and one-half to three minutes of CP …
Use of Beta-Blockers for the Treatment of Cardiac Arrest Due to Ventricular Fibrillation/Pulseless Ventricular Tachycardia: A Systematic ReviewFC de Oliveira et al. Resuscitation 83 (6), 674-83. PMID 22306254. - ReviewEven though the existing literature points toward a beneficial effect of beta-blockade in patients presenting with cardiac arrest due to VF/pulseless VT, high quality hum …
Outcomes Associated With Amiodarone and Lidocaine in the Treatment of In-Hospital Pediatric Cardiac Arrest With Pulseless Ventricular Tachycardia or Ventricular FibrillationSO Valdes et al. Resuscitation 85 (3), 381-6. PMID 24361455.For children with in-hospital pVT/VF, lidocaine use was independently associated with improved ROSC and 24-h survival. Amiodarone use was not associated with superior rat …
beta-Blockers for the Treatment of Cardiac Arrest From Ventricular Fibrillation?D Bourque et al. Resuscitation 75 (3), 434-44. PMID 17764805. - ReviewMore than 160,000 people suffer sudden cardiac death each year in the US. It is estimated that ventricular fibrillation (VF) is the initial rhythm in approximately 30% of …
Biphasic Versus Monophasic Waveforms for Transthoracic Defibrillation in Out-Of-Hospital Cardiac ArrestSC Faddy et al. Cochrane Database Syst Rev 2, CD006762. PMID 26904970. - ReviewIt is uncertain whether biphasic defibrillators have an important effect on defibrillation success in people with OHCA. Further large studies are needed to provide adequa …